Medicine
Revonto 20 mg/60 mL powder for injection
Revonto 20 mg/60 mL powder for injection is a prescription medicine containing Dantrolene for intravenous use, marketed by Uswm, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store unreconstituted product between 20°C to 25°C (68°F to 77°F) and avoid…
Key facts
- Active ingredient (INN)
- Dantrolene
- Brand
- Revonto
- Strength
- 20 mg/60 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 6 vials, 60 mL
- Marketing authorisation holder
- Uswm
- Manufacturers
- UswmProPharma Distribution
- Origin register
- US FDA, United States
- Storage
- Store unreconstituted product between 20°C to 25°C (68°F to 77°F) and avoid prolonged exposure to light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M03CA01 Dantrolene
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 April 2021
- Identifiers
- RxCUI 856696, 1012465DailyMed set ID f1650487-32bd-4017-b9c2-b38829a531af, 3edcfad5-00ad-7587-e063-6394a90addf3NDC 78670-003, 84549-003Application ANDA078378
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 vial, glass in 1 carton / 60 mL in 1 vial, glass | 78670-003-67 | Uswm | 9 April 2021 |
| 60 mL in 1 vial, glass | 84549-003-67 | ProPharma Distribution | 15 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dantrolene
Clinical summary
Dantrolene is a skeletal muscle relaxant indicated in controlling the manifestations of clinical spasticity resulting from upper motor neuron disorders (e.g., spinal cord injury, stroke, cerebral palsy, or multiple sclerosis), among other approved uses. MedsAcross supplies Dantrolene for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DantroleneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Dantrium prescribing information (Par Health) · U.S. National Library of Medicine, DailyMed
- Agilus: European public assessment report (EPAR) · European Medicines Agency
Need Revonto 20 mg/60 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.